-
Hyperacute Outer Retinal Dysfunction JAMA Ophthalmol. (IF 7.8) Pub Date : 2025-02-13 Yizhe Cheng, Xinyu Liu, Jinglin Lu, Jianing Ren, Ping Fei, Meini Chen, Changting Tang, Jianping Zhang, Minglian Zhang, Miner Yuan, Limei Sun, Linyan Zhang, Aohan Hou, Yili Jin, Yanting Lai, Qiong Wang, Wenjia Yan, Shuya Ke, Xiaoxin Li, Xiaoyan Ding
ImportancePattern recognition of pediatric retinal diseases can streamline the workup and guide the prognosis.ObjectiveTo characterize the clinical features, retinal imaging findings, and 1-year prognosis of pediatric patients who experienced sudden, severe bilateral vision loss with diffuse ellipsoid zone (EZ) and external limiting membrane (ELM) disruptions after fever.Design, Setting, and ParticipantsThis
-
Federally Qualified Health Centers as a Model to Improve Vision Health: A Systematic Review. JAMA Ophthalmol. (IF 7.8) Pub Date : 2025-02-13 Patricia Bai,Spencer S Burt,Maria A Woodward,Scott Haber,Paula Anne Newman-Casey,Jeffrey D Henderer,R V Paul Chan,Aiyin Chen,
Importance Disparities in eye health are associated with lower-income and minoritized populations, many of whom seek care at federally qualified health centers (FQHCs). Objective To examine the literature addressing vision and eye health care provided at FQHCs, identify barriers to providing care at FQHCs, and highlight recommendations on how FQHCs can decrease disparities in eye health. Evidence Review
-
Hyperacute Outer Retinal Dysfunction-A Retina on Fire. JAMA Ophthalmol. (IF 7.8) Pub Date : 2025-02-13 Timothy M Boyce,Ian C Han
-
Generative Artificial Intelligence Guidelines of Ophthalmology Journals. JAMA Ophthalmol. (IF 7.8) Pub Date : 2025-02-13 David E Rabinovitch,Jim S Xie,Adrien Lusterio,Andrew Mihalache,Marko M Popovic,Prashant D Tailor,Brendan Tao,Edward Margolin
-
Expanding Vision Services at Federally Qualified Health Centers. JAMA Ophthalmol. (IF 7.8) Pub Date : 2025-02-13 Sally S Ong
-
-
Can Medicare Data Describe COVID-19 Practice Pattern Changes? JAMA Ophthalmol. (IF 7.8) Pub Date : 2025-02-06 Sean T Berkowitz,Avni P Finn
-
Importance of Thickness When Evaluating Choroidal Tumors. JAMA Ophthalmol. (IF 7.8) Pub Date : 2025-02-06 Carol L Shields
-
Pixel Intensity to Estimate Choroidal Tumor Thickness Using 2-Dimensional Ultra-Widefield Images JAMA Ophthalmol. (IF 7.8) Pub Date : 2025-02-06 Michael D. Yu, Michael Heiferman, Edward Korot, Aneesha Ahluwalia, Gina Yu, Prithvi Mruthyunjaya
ImportanceTumor thickness is a well-established risk factor for malignant transformation of choroidal nevus into melanoma. To date, reliable evaluation of tumor thickness relies on B-scan ultrasonography, which is frequently unavailable at nonsubspecialty clinics where most melanocytic choroidal lesions (MCLs) are first diagnosed.ObjectiveTo describe a technique for potential rapid and reliable estimation
-
COVID-19 Pandemic and Rates of Common Ophthalmic Procedures Among Medicare Beneficiaries JAMA Ophthalmol. (IF 7.8) Pub Date : 2025-02-06 Raziyeh Mahmoudzadeh, Mariam Samuel, Sydney Wheeler, Mirataollah Salabati, Christopher T. Leffler, Jessica D. Randolph
ImportanceThe COVID-19 pandemic has altered health care delivery, including ophthalmic care. Understanding how the pandemic has changed the rates of commonly performed ophthalmic procedures is crucial for assessing the broader implications for patient care and resource allocation.ObjectiveTo estimate the changes in the rates of the 10 most prevalent ophthalmic procedures among Medicare beneficiaries
-
Primary Conjunctival Rhabdomyosarcoma Presenting as an Enlarging Papillomatous Lesion in a 3-Year-Old JAMA Ophthalmol. (IF 7.8) Pub Date : 2025-02-06 Zara Saleem, Alan D. Proia, Lars M. Wagner, Olivia J. Killeen, Sharon F. Freedman
This case report describes a rapidly growing conjunctival lesion in a 3-year-old patient, which was incompletely resected and diagnosed as rhabdomyosarcoma.
-
GLP-1 RAs and Nonarteritic Anterior Ischemic Optic Neuropathy-Making Sense of the Data. JAMA Ophthalmol. (IF 7.8) Pub Date : 2025-01-30 Mahyar Etminan,Mohit Sodhi,David Maberley
-
Adverse Events in a Mobile Eye Health Outreach Program JAMA Ophthalmol. (IF 7.8) Pub Date : 2025-01-30 Ryan Schmidt, Dove Spector, Verian Wedeking, Annette M. Totten, Mitchell V. Brinks
This survey study describes the postprocedure conditions experienced by individuals who received eye screening from the mobile Casey Outreach Program clinics in Oregon.
-
Ophthalmic Complications Associated With the Antidiabetic Drugs Semaglutide and Tirzepatide JAMA Ophthalmol. (IF 7.8) Pub Date : 2025-01-30 Bradley J. Katz, Michael S. Lee, Norah S. Lincoff, Anne S. Abel, Somya Chowdhary, Brian D. Ellis, Ahmad Najafi, John Nguyen, Meagan D. Seay, Judith E. A. Warner
ImportanceNearly 2% of the US population received a prescription for semaglutide in 2023. There has been a recent concern that this drug and other similar medications may be associated with ophthalmic complications.ObjectiveTo report ophthalmic complications associated with the use of semaglutide or tirzepatide.Design, Setting, and ParticipantsThis was a retrospective case series. All patients were
-
Photobiomodulation for Age-Related Macular Degeneration JAMA Ophthalmol. (IF 7.8) Pub Date : 2025-01-24 Srinivas R. Sadda
This Viewpoint examines results from the LIGHTSIDE trials for photobiomodulation to treat age-related macular degeneration and raises questions regarding the trial protocols and the efficacy and safety of the therapy.
-
Inflammation and Occlusive Retinal Vasculitis Post Faricimab JAMA Ophthalmol. (IF 7.8) Pub Date : 2025-01-23 Will Bruening, Sean Kim, Steven Yeh, Pukhraj Rishi, Christopher D. Conrady
ImportanceRandomized clinical trials have shown the safety and efficacy of faricimab as a novel vascular endothelial growth factor and angiopoietin-2 inhibitor in the treatment of neovascular age-related macular degeneration (nAMD) and macular edema of various etiologies. However, more rare adverse events may not be considered in clinical trials.ObjectiveTo describe 3 eyes that developed irreversible
-
Red Light Therapy for Myopia—Current Regulatory Changes in China JAMA Ophthalmol. (IF 7.8) Pub Date : 2025-01-23 Ya Xing Wang, Ningli Wang, Tien Yin Wong
This Viewpoint discusses the ophthalmic device, red light therapy, for myopia treatment in children and adolescents in China, including its development and use, safety concerns, and implications surrounding recent regulatory changes and reclassification of this device.
-
Femtosecond Laser Arcuate Keratotomy vs Toric Intraocular Lens Implantation in Cataract Surgery JAMA Ophthalmol. (IF 7.8) Pub Date : 2025-01-23 Yueyang Zhong, Shuying Chen, Hanle Wang, Su Li, Zhouyu Lu, Jingjie Xu, Yibo Yu, Ke Yao
ImportanceAfter cataract surgery, postoperative residual astigmatism can influence a patient’s visual quality and satisfaction. Finding ways to minimize this astigmatism is important.ObjectiveTo compare the clinical outcomes of femtosecond laser arcuate keratotomy (FSAK) and toric intraocular lens (TIOL) implantation for astigmatism correction in patients undergoing femtosecond laser-assisted cataract
-
Axial Growth and Myopia Progression After Discontinuing Soft Multifocal Contact Lens Wear. JAMA Ophthalmol. (IF 7.8) Pub Date : 2025-01-16 David A Berntsen,Anita Ticak,Danielle J Orr,Amber Gaume Giannoni,Loraine T Sinnott,Donald O Mutti,Lisa A Jones-Jordan,Jeffrey J Walline,
Importance For myopia control to be beneficial, it would be important that the benefit of treatment (slowed eye growth) is not lost because of faster than normal growth (rebound) after discontinuing treatment. Objective To determine whether there is a loss of treatment effect (rebound) after discontinuing soft multifocal contact lenses in children with myopia. Design, Setting, and Participants The
-
Myopia Control-Are We Getting Any Closer? JAMA Ophthalmol. (IF 7.8) Pub Date : 2025-01-16 Lori Ann F Kehler,David K Wallace
-
Bilateral Mumps-Associated Retinitis in an Unvaccinated Male. JAMA Ophthalmol. (IF 7.8) Pub Date : 2025-01-16 Radhika Sriram,Padmamalini Mahendradas,Rohit Shetty
-
Temperature Excursion of Patient-Purchased Anti-VEGF Agents-A Cause for Concern? JAMA Ophthalmol. (IF 7.8) Pub Date : 2025-01-16 Jason Fan,Harry W Flynn,Nicolas A Yannuzzi
-
Optic Nerve Melanocytoma With Vitreous Seeding JAMA Ophthalmol. (IF 7.8) Pub Date : 2025-01-16 Brian R. Coleman, Sander R. Dubovy, Basil K. Williams
This case report discusses a diagnosis of optic nerve melanocytoma in a woman aged 55 years who presented with progressive painless vision loss over a 7-month period.
-
Temperature Excursion of Intravitreal Anti-VEGF Agents During Home Storage JAMA Ophthalmol. (IF 7.8) Pub Date : 2025-01-16 Inès Ben Ghezala, Laure-Anne Steinberg, Maxime Sibert, Aline Lazzarotti, Aude Ambresin, Pierre-Henry Gabrielle, Catherine Creuzot-Garcher
ImportanceSome patients worldwide are asked to acquire an anti–vascular endothelial growth factor (anti-VEGF) agent from a pharmacy, store it, and then bring it to a physician for intravitreal injection (IVT). Anti-VEGF agents must be stored in the refrigerator to avoid bacterial contamination or denaturation. Some cases of severe intraocular inflammation have been reported following IVT of more recently
-
Representation Quotients to Examine Diversity in Ophthalmology Residency Applicants and Matriculants JAMA Ophthalmol. (IF 7.8) Pub Date : 2025-01-16 Saba S. Paracha, Shani A. Williams, Alizeh Shamshad, Elijah M. Persad-Paisley, Michael E. Migliori
ImportanceA diverse ophthalmic workforce is key to equitable care, and identifying areas of underrepresentation is important in tackling vision care disparities.ObjectiveTo evaluate the diversity of applicants and matriculants in ophthalmology residency programs relative to medical school graduates and analyze the intersection of race and gender within this pathway.Design, Setting, and ParticipantsThis
-
Retinal Vasculitis Associated With Castleman Disease JAMA Ophthalmol. (IF 7.8) Pub Date : 2025-01-16 Yujing Qian, Meifen Zhang
This case report describes a diagnosis of retinal vasculitis associated with Castleman disease in a man who presented with 6 months of progressive floaters bilaterally and no change in visual acuity.
-
Fever and Floaters in a 56-Year-Old Woman JAMA Ophthalmol. (IF 7.8) Pub Date : 2025-01-16 Kim Firn, Justin Youn, David Sierpina
A 56-year-old woman presents with fever, headache, nausea, and vomiting. Computed tomography scan of the head shows multiple coarse, dystrophic calcifications, and she reports floaters with normal vision. What would you do next?
-
Efficacy and Safety of Different Atropine Regimens for the Treatment of Myopia in Children JAMA Ophthalmol. (IF 7.8) Pub Date : 2025-01-09 James Loughman, Gareth Lingham, Ernest Kyei Nkansah, Emmanuel Kobia-Acquah, Daniel Ian Flitcroft
ImportanceAdditional data are required regarding atropine treatment regimens for control of myopia progression.ObjectiveTo investigate the efficacy and safety of different atropine regimens for myopia in children.Design, Setting, and ParticipantsThis was a secondary analysis of the 3-year results of the 24-Month Myopia Outcome Study of Atropine in Children (MOSAIC) trial, called the MOSAIC2 trial.
-
Safety and Vision Outcomes Following Gene Therapy for Bietti Crystalline Dystrophy JAMA Ophthalmol. (IF 7.8) Pub Date : 2025-01-09 Xiuju Chen, Xiao Liu, Shihe Cui, Gang Wang, Yiting Liu, Guang Qu, Lixin Jiang, Yong Liu, Xiaoxin Li
ImportanceBietti crystalline dystrophy (BCD) is a severe genetic retinopathy caused by variants in the CYP4V2 gene. Currently, there is no approved treatment for BCD.ObjectiveTo evaluate safety and vision outcomes following gene therapy with adeno-associated virus (AAV) encoding CYP4V2 (rAAV-hCYP4V2, NGGT001 [Next Generation Gene Therapeutics]).Design, Setting, and ParticipantsThis open-label, dose-escalation
-
Pediatric Patient Referred for an Optic Nerve Mass JAMA Ophthalmol. (IF 7.8) Pub Date : 2025-01-02 Justin J. Grassmeyer, Alison H. Skalet, Benjamin K. Young
A 13-year-old male patient was referred for evaluation of an optic nerve mass with decreased central vision and occasional pain. Examination revealed an afferent pupillary defect, a few vitreous cells, and an optic nerve lesion associated with a small peripapillary hemorrhage, peripapillary subretinal fluid, and scattered white lesions in the inferior retinal periphery. What would you do next?
-
The Rural Shortage of Ophthalmic Subspecialists. JAMA Ophthalmol. (IF 7.8) Pub Date : 2025-01-02 Sophia Y Wang
-
Geographic Distribution of US Ophthalmic Surgical Subspecialists JAMA Ophthalmol. (IF 7.8) Pub Date : 2025-01-02 Aishah Ahmed, Muhammad Ali, Chen Dun, Cindy X. Cai, Martin A. Makary, Fasika A. Woreta
ImportanceWhile urban counties maintain higher densities of ophthalmologists than rural counties, the geographic distribution of ophthalmic surgical subspecialists has not yet been elucidated. A potential workforce discrepancy may impact the burden of care faced by rural surgeons.ObjectiveTo assess the geographic distribution of the ophthalmic subspecialist surgeon workforce and evaluate factors associated
-
Ultra-Widefield Optical Coherence Tomography Beyond the Ora Serrata in Retinopathy of Prematurity JAMA Ophthalmol. (IF 7.8) Pub Date : 2024-12-26 Elizabeth V. Roti, Shuibin Ni, Yakub Bayhaqi, Susan R. Ostmo, Spencer S. Burt, Mani K. Woodward, John D. Jackson, Aaron S. Coyner, Michael F. Chiang, David Huang, J. Peter Campbell, Yifan Jian, Benjamin K. Young
ImportanceCapturing high-quality images of the entire peripheral retina while minimizing the use of scleral depression could increase the quality of examinations for retinopathy of prematurity (ROP) while reducing neonatal stress.ObjectiveTo evaluate whether an investigational handheld ultra-widefield optical coherence tomography (UWF-OCT) device without scleral depression can be used to document high-quality
-
Efficacy and Safety of Mydriatic Microdrops for Retinopathy of Prematurity Screening JAMA Ophthalmol. (IF 7.8) Pub Date : 2024-12-26 Aikaterini K. Seliniotaki, Maria Lithoxopoulou, Christina Virgiliou, Helen Gika, Aristides Dokoumetzidis, Konstantinos I. Bougioukas, Nikolaos Raikos, Elisavet Diamanti, Nikolaos Ziakas, Anna-Bettina Haidich, Asimina Mataftsi
ImportanceCommercial mydriatics administered in preterm infants during retinopathy of prematurity (ROP) screening have been associated with various cardiorespiratory and gastrointestinal adverse events.ObjectiveTo examine whether microdrops of a combined mixture of 1.67% phenylephrine and 0.33% tropicamide are noninferior to standard drops regarding mydriatic efficacy at 45, 90, and 120 minutes. The
-
Bilateral Acute Optic Neuropathy in a Teenaged Girl JAMA Ophthalmol. (IF 7.8) Pub Date : 2024-12-26 Jiahui Wu, Zhengyu Wang, Lili Lang
A 14-year old girl presents with sudden painless vision decline in the left eye for 5 days and reports constant fatigue, occasional dizziness, mild pain in the lower limbs, and intermittent claudication over the past 12 months with no history of trauma, surgery, COVID-19 infection, influenza, or other infection. What would you do next?
-
Single-Eye Gene Therapy for Leber Hereditary Optic Neuropathy. JAMA Ophthalmol. (IF 7.8) Pub Date : 2024-12-19 Hendrik P N Scholl,Bence György
-
Bilateral Retinal Nerve Fiber Layer Thickening in a Middle-Aged Woman JAMA Ophthalmol. (IF 7.8) Pub Date : 2024-12-19 Ivy Zhu, Amani A. Fawzi
A middle-aged Hispanic woman presented for evaluation of an asymptomatic epiretinal membrane in the left eye. She had an ocular history of amblyopia in the left eye, a medical history significant for chronic neuropathy, ataxia, and myelopathy of unknown etiology, and nystagmus on examination. Genetic testing revealed variants in the SACS and SLC5A7 genes. What is your diagnosis?
-
Quantifying Patient Preferences and Expectations About Diabetic Retinopathy Monitoring JAMA Ophthalmol. (IF 7.8) Pub Date : 2024-12-19 Juan Marcos Gonzalez Sepulveda, Jui-Chen Yang, Alicja Mastylak, Elaine M. Wells-Gray, Landon Grace, Stephen Fransen
ImportanceDiabetic retinopathy (DR) is the leading cause of blindness among adults in the US. The US Centers for Disease Control and Prevention recommends annual DR monitoring for all individuals with diabetes, yet monitoring rates remain below 70%.ObjectiveTo evaluate how patient preferences and expectations about DR monitoring are associated with expected monitoring adherence behaviors.Design, Setting
-
Five-Year Outcomes of Lenadogene Nolparvovec Gene Therapy in Leber Hereditary Optic Neuropathy. JAMA Ophthalmol. (IF 7.8) Pub Date : 2024-12-19 Patrick Yu-Wai-Man,Nancy J Newman,Valérie Biousse,Valerio Carelli,Mark L Moster,Catherine Vignal-Clermont,Thomas Klopstock,Alfredo A Sadun,Robert C Sergott,Rabih Hage,Simona Degli Esposti,Chiara La Morgia,Claudia Priglinger,Rustum Karanja,Magali Taiel,José-Alain Sahel,
Importance Limited studies have assessed the long-term benefit/risk of gene therapy for Leber hereditary optic neuropathy (LHON). Objective To determine the safety and efficacy of lenadogene nolparvovec in patients with LHON due to the MT-ND4 gene variant for up to 5 years after administration. Design, Setting, and Participants The RESCUE and REVERSE Long-Term Follow-up Study (RESTORE), conducted from
-
Cotton Swab Couching of Dislocated Crystalline Lens in Marfan Syndrome. JAMA Ophthalmol. (IF 7.8) Pub Date : 2024-12-19 Sophie Z Gu,Jin Kyun Oh,Jason D Horowitz
-
Retinal Annular Ring Lines of White Without Pressure. JAMA Ophthalmol. (IF 7.8) Pub Date : 2024-12-19 Mengmeng Zhang,Man Du,Shuting Wang
-
Novel In-Office Procedure for Retinal Detachment. JAMA Ophthalmol. (IF 7.8) Pub Date : 2025-01-01 Jacob S Heng,Yannis M Paulus
-
Fovea-Involved Outer Retinal Abnormality Induced by a Novel RET Inhibitor JAMA Ophthalmol. (IF 7.8) Pub Date : 2024-12-12 Langxuan Yuan, Shan Gao, Shimin Tan, Qianyan Kang, Jianqin Lei
This case report describes an outer retinal abnormality associated with taking a RET inhibitor during a clinical trial in a 52-year-old patient with right lung adenocarcinoma and a RET gene fusion.
-
In-Office Suprachoroidal Viscopexy for Acute Rhegmatogenous Retinal Detachment JAMA Ophthalmol. (IF 7.8) Pub Date : 2024-12-12 Rajeev H. Muni, Isabela Martins Melo, Sueellen Demian, Tomas Minelli, Hatim Batawi, John Park, Aurora Pecaku
ImportanceIn-office suprachoroidal viscopexy (SCVEXY) is a relatively new procedure for rhegmatogenous retinal detachment (RRD), but minimal information is available regarding outcomes and safety.ObjectiveTo report outcomes with in-office SCVEXY for primary acute RRD.Design, Setting, and ParticipantsThis retrospective case series was conducted at St Michael’s Hospital in Toronto, Ontario, Canada from
-
Risk Factors for Retinopathy in Young Adults With Type 1 Diabetes. JAMA Ophthalmol. (IF 7.8) Pub Date : 2024-12-12 Shilan Seyed Ahmadi,Johnny Ludvigsson,Henrik Imberg,Thomas Nyström,Marcus Lind
-
Progressive Eyelid Lesions in a Woman With Essential Thrombocythemia JAMA Ophthalmol. (IF 7.8) Pub Date : 2024-12-12 Akshara R. Legala, Marissa K. Shoji, Don O. Kikkawa
A 75-year-old woman with a history of essential thrombocythemia presented with 3 months of progressively enlarging right upper eyelid lesions. Examination revealed a thickened eyelid margin, madarosis, and erythema with some tenderness to palpation but an otherwise normal ocular examination. What would you do next?
-
Diabetic Retinopathy-Another Possible Target for SGLT2 Inhibitors? JAMA Ophthalmol. (IF 7.8) Pub Date : 2025-01-01 Jonathan E Shaw,Alicia J Jenkins
-
Discrimination Within the US Ophthalmology Workforce JAMA Ophthalmol. (IF 7.8) Pub Date : 2024-12-05 Shreya Sirivolu, Sarah Pike, Mark W. Reid, Jesse L. Berry, Melinda Y. Chang, Angeline M. Nguyen
ImportanceDiscrimination in the workforce is a barrier to achieving diversity, equity, and inclusion. A previous study of ophthalmologists in Australia and New Zealand reported high rates of discrimination, but little is known about discrimination among ophthalmologists in the US.ObjectiveTo describe the frequency, nature, and outcomes of discrimination experienced by US ophthalmologists and trainees
-
Empagliflozin and the Risk of Retinopathy in Patients With Type 2 Diabetes JAMA Ophthalmol. (IF 7.8) Pub Date : 2024-12-05 Helen Tesfaye, Julie M. Paik, Miin Roh, Phyo T. Htoo, Heidi Zakoul, Niklas Schmedt, Lisette Koeneman, Deborah J. Wexler, Elisabetta Patorno
ImportanceEmpagliflozin might lower the risk of diabetic retinopathy (DR) by preventing retinal pericyte loss. However, the role of empagliflozin with respect to DR in patients with type 2 diabetes (T2D) remains unclear.ObjectiveTo compare the risk of incident nonproliferative DR (NPDR) and DR progression in patients with T2D initiating empagliflozin vs a dipeptidyl peptidase 4 inhibitor (DPP4i).Design
-
Visual Deficits in Patients With Mild Traumatic Brain Injury. JAMA Ophthalmol. (IF 7.8) Pub Date : 2025-01-01 Madeleine K Nowak,Francesca C Fortenbaugh,David H Salat
-
Strongyloides stercoralis Choroiditis JAMA Ophthalmol. (IF 7.8) Pub Date : 2024-11-27 Madelynn Corda, Jonathan Shepherd, Alan D. Proia
This case report describes a patient whose autopsy revealed that the posterior choroid of the right eye had a focal eosinophil-rich inflammatory infiltrate with a cross-section of a possible degenerating Strongyloides stercoralis larva and a coiled, incompletely sectioned, filariform larva in a medium-caliber choroidal artery.
-
Primary Visual Pathway Changes in Individuals With Chronic Mild Traumatic Brain Injury JAMA Ophthalmol. (IF 7.8) Pub Date : 2024-11-27 Marselle A. Rasdall, Chloe Cho, Amy N. Stahl, David A. Tovar, Patrick Lavin, Cailey I. Kerley, Qingxia Chen, Xiangyu Ji, Marcus H. Colyer, Lucas Groves, Reid Longmuir, Amy Chomsky, Martin J. Gallagher, Adam Anderson, Bennett A. Landman, Tonia S. Rex
ImportanceIndividuals with mild traumatic brain injury (TBI) often report vision problems despite having normal visual acuity and fundus examinations. Diagnostics are needed for these patients.ObjectiveTo determine if a battery of assessments or machine-learning approaches can aid in diagnosing visual dysfunction in patients with mild TBI.Design, Setting, and ParticipantsThis prospective, observational
-
Macular Capillary Nonperfusion in Eyes With Stable Laser-Treated Proliferative Diabetic Retinopathy JAMA Ophthalmol. (IF 7.8) Pub Date : 2024-11-27 Sridevi Thottarath, Wei-Shan Tsai, Sarega Gurudas, Elizabeth Pearce, Chui Ming Gemmy Cheung, Taffeta Ching Ning Yamaguchi, Sobha Sivaprasad
ImportanceSome eyes with proliferative diabetic retinopathy (PDR) treated to stability with panretinal photocoagulation (PRP) continue to lose vision without diabetic macular edema. One presumed cause is macular capillary nonperfusion (CNP)–associated ischemia or infarction. Natural history data of macular CNP might guide treatment trials for it.ObjectiveTo assess visual function and optical coherence
-
The Emerging Clinical Utility of Polygenic Prediction Models. JAMA Ophthalmol. (IF 7.8) Pub Date : 2025-01-01 Anthony P Khawaja,Pirro G Hysi,Paul J Foster
-
Looking Beyond and Behind a Retinal Detachment JAMA Ophthalmol. (IF 7.8) Pub Date : 2024-11-21 Shahriyar P. Majidi, Ashley A. Campbell, Bryn Burkholder
A 63-year-old woman with a history of type 1 diabetes presents with gradually progressive vision loss in the right eye for the past year. What would you do next?
-
Predictive Power of Polygenic Risk Scores for Intraocular Pressure or Vertical Cup-Disc Ratio JAMA Ophthalmol. (IF 7.8) Pub Date : 2024-11-21 Weixiong He, Samantha Sze-Yee Lee, Santiago Diaz Torres, Xikun Han, Puya Gharahkhani, Michael Hunter, Chandrakumar Balartnasingam, Jamie E. Craig, Alex W. Hewitt, David A. Mackey, Stuart MacGregor
ImportanceEarly detection of glaucoma is essential to timely monitoring and treatment, and primary open-angle glaucoma risk can be assessed by measuring intraocular pressure (IOP) or optic nerve head vertical cup-disc ratio (VCDR). Polygenic risk scores (PRSs) could provide a link between genetic effects estimated from genome-wide association studies (GWASs) and clinical applications to provide estimates
-
Luxated Globe at Birth-A Vision-Threatening Emergency. JAMA Ophthalmol. (IF 7.8) Pub Date : 2024-11-21 Aline Ramos da Silva,Mariana Nadais Aidar,Antonio Augusto Velasco Cruz
-
Skin Discoloration After Iatrogenic Fluorescein Dosing Error JAMA Ophthalmol. (IF 7.8) Pub Date : 2024-11-21 Pamela D. Moore, Michele M. Burns
This case report describes a diagnosis of iatrogenic fluorescein dosing error in a girl aged 10 months who presented for routine fluorescein angiography examination in the setting of incontinentia pigmenti.
-
Performance of Polygenic Risk Scores for Primary Open-Angle Glaucoma in Populations of African Descent. JAMA Ophthalmol. (IF 7.8) Pub Date : 2025-01-01 Jennifer M Chang-Wolf,Tyler G Kinzy,Sjoerd J Driessen,Lauren A Cruz,Sudha K Iyengar,Neal S Peachey,Tin Aung,Chiea Chuen Khor,Susan E Williams,Michele Ramsay,Olusola Olawoye,Adeyinka Ashaye,Caroline C W Klaver,Michael A Hauser,Alberta A H J Thiadens,Jessica N Cooke Bailey,Pieter W M Bonnemaijer,
Importance Primary open-angle glaucoma (POAG) polygenic risk scores (PRSs) continue to be evaluated in primarily European-ancestry populations despite higher prevalence and worse outcomes in African-ancestry populations. Objective To evaluate how established POAG PRSs perform in African-ancestry samples from the Genetics in Glaucoma Patients of African Descent (GIGA), Genetics of Glaucoma in Individuals
-
Implications of Diagnostic Error in Ocular Surface Disease: The Role of Anchoring and Ambiguous Diagnostic Terminology. JAMA Ophthalmol. (IF 7.8) Pub Date : 2025-01-01 Todd P Margolis,Anat Galor,Gary D Novack